Related Experiment Video
Updated: Jul 30, 2025

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
COVID-19 and Cardiovascular Diseases: From Cellular Mechanisms to Clinical Manifestations
Hongyang Shu1,2, Zheng Wen1,2, Na Li1,2
1Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430000, China.
Insights
Coronavirus disease 2019 (COVID-19) significantly impacts cardiovascular health, increasing risks for patients with pre-existing conditions and causing new cardiac issues post-infection and vaccination.
Area of Science:
- Cardiology
- Infectious Diseases
- Virology
Background:
- COVID-19, caused by SARS-CoV-2, has led to a global health crisis with significant mortality.
- The virus primarily infects cells via the ACE2 receptor, which is also present in cardiac tissue.
- A strong association between COVID-19 and cardiovascular disease (CVD) is increasingly evident.
Purpose of the Study:
- To review the multifaceted impact of COVID-19 on cardiovascular health.
- To elucidate the mechanisms underlying COVID-19's cardiovascular complications.
- To discuss cardiovascular risks post-recovery and those associated with vaccination.
Main Methods:
- Review of existing clinical evidence and scientific literature.
- Analysis of the effects of SARS-CoV-2 on various myocardial cell types.
- Overview of clinical manifestations of cardiovascular involvement during the pandemic.
Main Results:
- COVID-19 exacerbates pre-existing cardiovascular conditions and can lead to new cardiac issues like myocardial damage, heart failure, and thromboembolism.
- The virus affects cardiomyocytes, pericytes, endothelial cells, and fibroblasts within the heart.
- Increased cardiovascular risks are observed both after COVID-19 recovery and following vaccination.
Conclusions:
- COVID-19 poses a significant threat to cardiovascular health through direct viral effects and exacerbation of underlying conditions.
- Understanding the cardiovascular impact is crucial for managing patients during and after the pandemic.
- Further research is needed on long-term cardiovascular consequences and vaccine-related cardiac events.
Abstract:
Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), quickly spread worldwide and led to over 581 million confirmed cases and over 6 million deaths as 1 August 2022. The binding of the viral surface spike protein to the human angiotensin-converting enzyme 2 (ACE2) receptor is the primary mechanism of SARS-CoV-2 infection. Not only highly expressed in the lung, ACE2 is also widely distributed in the heart, mainly in cardiomyocytes and pericytes. The strong association between COVID-19 and cardiovascular disease (CVD) has been demonstrated by increased clinical evidence. Preexisting CVD risk factors, including obesity, hypertension, and diabetes etc., increase susceptibility to COVID-19. In turn, COVID-19 exacerbates the progression of CVD, including myocardial damage, arrhythmia, acute myocarditis, heart failure, and thromboembolism. Moreover, cardiovascular risks post recovery and the vaccination-associated cardiovascular problems have become increasingly evident. To demonstrate the association between COVID-19 and CVD, this review detailly illustrated the impact of COVID-19 on different cells (cardiomyocytes, pericytes, endothelial cells, and fibroblasts) in myocardial tissue and provides an overview of the clinical manifestations of cardiovascular involvements in the pandemic. Finally, the issues related to myocardial injury post recovery, as well as vaccination-induced CVD, has also been emphasized.
More Related Videos
08:35Oxygenation-sensitive Cardiac MRI with Vasoactive Breathing Maneuvers for the Non-invasive Assessment of Coronary Microvascular Dysfunction
Published on: August 17, 2022
07:56Monitoring Changes in Human Umbilical Vein Endothelial Cells upon Viral Infection Using Impedance-Based Real-Time Cell Analysis
Published on: May 5, 2023
Related Concept Videos
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease I: Introduction